Home > Research > Publications & Outputs > The feasibility and acceptability of a novel an...

Electronic data

  • Anxiety_outcome_paper_plain_text_revision_clean_01.05.18

    Rights statement: This is the peer reviewed version of the following article: Jones SH, Knowles D, Tyler E, et al. The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: A randomized controlled trial. Depress Anxiety. 2018;35:953–965. https://doi.org/10.1002/da.22781 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/da.22781/abstract This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Accepted author manuscript, 872 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: a randomized controlled trial

Research output: Contribution to journalJournal articlepeer-review

Published

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{2b6ac79c4f944c2386b7566213fd1463,
title = "The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: a randomized controlled trial",
abstract = "1 BackgroundComorbid anxiety is common in bipolar disorder (BD) and associated with worse clinical outcomes including increased suicidality. Despite effective psychological treatments for anxiety, research into treating anxiety in BD is underdeveloped. This paper describes a novel psychological intervention to address anxiety in context of bipolar disorder (AIBD).2 MethodsAdults with BD and clinically significant anxiety symptoms were randomized to AIBD plus treatment as usual (TAU) or TAU alone. AIBD offered 10 sessions of psychological therapy using a formulation‐based approach. Feasibility and acceptability were evaluated through recruitment, retention, therapy attendance, alliance, fidelity, and qualitative feedback. Clinical outcomes were assessed at baseline, 16, 48, and 80 weeks: interim assessments of relapse at 32 and 64 weeks.3 ResultsSeventy‐two participants were recruited with 88% retention to 16 weeks and 74% to 80 weeks (similar between arms). Therapy participants attended urn:x-wiley:10914269:media:da22781:da22781-math-00017.7 (SD 2.8) sessions. Therapeutic alliance and therapy fidelity were acceptable. Qualitative interviews indicated that participants valued integrated support for anxiety with BD and coping strategies. Some suggested a longer intervention period. Clinical outcomes were not significantly different between arms up to 80 weeks follow‐up.4 ConclusionsAIBD is feasible and acceptable but lack of impact on clinical outcomes indicates that adaptations are required. These are discussed in relation to qualitative feedback and recent literature published since the trial completed.",
keywords = "Bipolar disorder, Anxiety/Anxiety disorders , CBT/cognitive behavior therapy, mood disorders, Clinical Trials",
author = "Jones, {Steven Huntley} and Dawn Knowles and Elizabeth Tyler and Fiona Holland and Sarah Peters and Lobban, {Anne Fiona} and Brian Langshaw and Hilton, {Claire Alexandra} and Long, {Rita Marie} and Kay Gantt and Owen, {Rebecca Louise} and Christopher Roberts and Riste, {Lisa Kate}",
note = "This is the peer reviewed version of the following article: Jones SH, Knowles D, Tyler E, et al. The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: A randomized controlled trial. Depress Anxiety. 2018;35:953–965. https://doi.org/10.1002/da.22781 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/da.22781/abstract This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.",
year = "2018",
month = oct,
doi = "10.1002/da.22781",
language = "English",
volume = "35",
pages = "953--965",
journal = "Depression and Anxiety",
issn = "1091-4269",
publisher = "Wiley-Blackwell",
number = "10",

}

RIS

TY - JOUR

T1 - The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual

T2 - a randomized controlled trial

AU - Jones, Steven Huntley

AU - Knowles, Dawn

AU - Tyler, Elizabeth

AU - Holland, Fiona

AU - Peters, Sarah

AU - Lobban, Anne Fiona

AU - Langshaw, Brian

AU - Hilton, Claire Alexandra

AU - Long, Rita Marie

AU - Gantt, Kay

AU - Owen, Rebecca Louise

AU - Roberts, Christopher

AU - Riste, Lisa Kate

N1 - This is the peer reviewed version of the following article: Jones SH, Knowles D, Tyler E, et al. The feasibility and acceptability of a novel anxiety in bipolar disorder intervention compared to treatment as usual: A randomized controlled trial. Depress Anxiety. 2018;35:953–965. https://doi.org/10.1002/da.22781 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/da.22781/abstract This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2018/10

Y1 - 2018/10

N2 - 1 BackgroundComorbid anxiety is common in bipolar disorder (BD) and associated with worse clinical outcomes including increased suicidality. Despite effective psychological treatments for anxiety, research into treating anxiety in BD is underdeveloped. This paper describes a novel psychological intervention to address anxiety in context of bipolar disorder (AIBD).2 MethodsAdults with BD and clinically significant anxiety symptoms were randomized to AIBD plus treatment as usual (TAU) or TAU alone. AIBD offered 10 sessions of psychological therapy using a formulation‐based approach. Feasibility and acceptability were evaluated through recruitment, retention, therapy attendance, alliance, fidelity, and qualitative feedback. Clinical outcomes were assessed at baseline, 16, 48, and 80 weeks: interim assessments of relapse at 32 and 64 weeks.3 ResultsSeventy‐two participants were recruited with 88% retention to 16 weeks and 74% to 80 weeks (similar between arms). Therapy participants attended urn:x-wiley:10914269:media:da22781:da22781-math-00017.7 (SD 2.8) sessions. Therapeutic alliance and therapy fidelity were acceptable. Qualitative interviews indicated that participants valued integrated support for anxiety with BD and coping strategies. Some suggested a longer intervention period. Clinical outcomes were not significantly different between arms up to 80 weeks follow‐up.4 ConclusionsAIBD is feasible and acceptable but lack of impact on clinical outcomes indicates that adaptations are required. These are discussed in relation to qualitative feedback and recent literature published since the trial completed.

AB - 1 BackgroundComorbid anxiety is common in bipolar disorder (BD) and associated with worse clinical outcomes including increased suicidality. Despite effective psychological treatments for anxiety, research into treating anxiety in BD is underdeveloped. This paper describes a novel psychological intervention to address anxiety in context of bipolar disorder (AIBD).2 MethodsAdults with BD and clinically significant anxiety symptoms were randomized to AIBD plus treatment as usual (TAU) or TAU alone. AIBD offered 10 sessions of psychological therapy using a formulation‐based approach. Feasibility and acceptability were evaluated through recruitment, retention, therapy attendance, alliance, fidelity, and qualitative feedback. Clinical outcomes were assessed at baseline, 16, 48, and 80 weeks: interim assessments of relapse at 32 and 64 weeks.3 ResultsSeventy‐two participants were recruited with 88% retention to 16 weeks and 74% to 80 weeks (similar between arms). Therapy participants attended urn:x-wiley:10914269:media:da22781:da22781-math-00017.7 (SD 2.8) sessions. Therapeutic alliance and therapy fidelity were acceptable. Qualitative interviews indicated that participants valued integrated support for anxiety with BD and coping strategies. Some suggested a longer intervention period. Clinical outcomes were not significantly different between arms up to 80 weeks follow‐up.4 ConclusionsAIBD is feasible and acceptable but lack of impact on clinical outcomes indicates that adaptations are required. These are discussed in relation to qualitative feedback and recent literature published since the trial completed.

KW - Bipolar disorder

KW - Anxiety/Anxiety disorders

KW - CBT/cognitive behavior therapy

KW - mood disorders

KW - Clinical Trials

U2 - 10.1002/da.22781

DO - 10.1002/da.22781

M3 - Journal article

VL - 35

SP - 953

EP - 965

JO - Depression and Anxiety

JF - Depression and Anxiety

SN - 1091-4269

IS - 10

ER -